Literature DB >> 32617851

Cerebral Energy Status and Altered Metabolism in Early Severe TBI: First Results of a Prospective 31P-MRS Feasibility Study.

Daniel Pinggera1, Ruth Steiger2,3, Marlies Bauer1, Johannes Kerschbaumer1, Markus Luger4, Ronny Beer5, Andreas Rietzler2,3, Astrid E Grams6,7, Elke R Gizewski2,3, Claudius Thomé1, Ondra Petr1.   

Abstract

OBJECTIVE: Severe traumatic brain injury (sTBI) represents a serious public health issue with high morbidity and mortality. Neuroimaging plays a crucial role in the evaluation of sTBI patients. Phosphorous magnetic resonance spectroscopy (31P-MRS) is an imaging technique for evaluation of energy metabolites. The aim of this study is to evaluate the feasibility and the diagnostic potential of ultra-early 31P-MRS to detect changes in cerebral energy metabolism in sTBI.
METHODS: Adult patients with sTBI presenting with GCS ≤ 8 being eligible for MRI were prospectively included in the study and MRI was performed within 72 h after trauma. Imaging was performed using a 3 Tesla MRI. 31P-MRS data from the structurally affected side were compared to data from normal appearing contralateral areas symmetrically to the location of the traumatic lesions, and to data of matched healthy controls.
RESULTS: Ten sTBI patients (3 female, 7 male), aged between 20 and 75 years, with a mean initial GCS of 6 were analyzed. MRI was performed 61 h (mean, range 37-71 h) after trauma. Statistical analysis revealed no significant differences between the lesioned side and contralaterally. An increased PCr/ATP ratio and a decreased PME/PDE ratio were present in structurally normal appearing, but traumatized tissue when compared to the healthy population, thus indicating significant differences in ATP resynthesis and membrane turnover (F (2,33), P = 0.005 and, P = 0.027, respectively).
CONCLUSION: 31P-MRS could provide a better understanding of pertinent global changes in cerebral energy metabolism in sTBI patients under general anesthesia.

Entities:  

Keywords:  Energy Metabolism; MR Spectroscopy; Severe TBI

Year:  2021        PMID: 32617851     DOI: 10.1007/s12028-020-01042-x

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  43 in total

1.  Decreased brain PME/PDE ratio in bipolar disorder: a preliminary (31) P magnetic resonance spectroscopy study.

Authors:  Xian-Feng Shi; Paul J Carlson; Young-Hoon Sung; Kristen K Fiedler; Lauren N Forrest; Tracy L Hellem; Rebekah S Huber; Seong-Eun Kim; Chun Zuo; Eun-Kee Jeong; Perry F Renshaw; Douglas G Kondo
Journal:  Bipolar Disord       Date:  2015-10-19       Impact factor: 6.744

Review 2.  Molecular features assisting in diagnosis, surgery, and treatment decision making in low-grade gliomas.

Authors:  Ricky Chen; Vijay M Ravindra; Adam L Cohen; Randy L Jensen; Karen L Salzman; Andrew P Prescot; Howard Colman
Journal:  Neurosurg Focus       Date:  2015-03       Impact factor: 4.047

Review 3.  Advances in neuroimaging of traumatic brain injury and posttraumatic stress disorder.

Authors:  Robert W Van Boven; Greg S Harrington; David B Hackney; Andreas Ebel; Grant Gauger; J Douglas Bremner; Mark D'Esposito; John A Detre; E Mark Haacke; Clifford R Jack; William J Jagust; Denis Le Bihan; Chester A Mathis; Susanne Mueller; Pratik Mukherjee; Norbert Schuff; Anthony Chen; Michael W Weiner
Journal:  J Rehabil Res Dev       Date:  2009

4.  Energy status and metabolism in intracranial space occupying lesions: a prospective 31p spectroscopic study.

Authors:  Ravindra Bhimrao Kamble; Jayakumar Peruvumba N; Ravishankar Shivashankar
Journal:  J Clin Diagn Res       Date:  2014-11-20

Review 5.  Complications of invasive intracranial pressure monitoring devices in neurocritical care.

Authors:  Samon Tavakoli; Geoffrey Peitz; William Ares; Shaheryar Hafeez; Ramesh Grandhi
Journal:  Neurosurg Focus       Date:  2017-11       Impact factor: 4.047

6.  Blood glucose concentration does not affect outcome in brain trauma: A 31P MRS study.

Authors:  R Vink; E M Golding; J P Williams; T K McIntosh
Journal:  J Cereb Blood Flow Metab       Date:  1997-01       Impact factor: 6.200

Review 7.  Brain multimodality monitoring: an update.

Authors:  Mauro Oddo; Federico Villa; Giuseppe Citerio
Journal:  Curr Opin Crit Care       Date:  2012-04       Impact factor: 3.687

8.  Regional energetic dysfunction in hippocampal epilepsy.

Authors:  J W Pan; J H Kim; A Cohen-Gadol; C Pan; D D Spencer; H P Hetherington
Journal:  Acta Neurol Scand       Date:  2005-04       Impact factor: 3.209

9.  Altered phospholipid metabolism in schizophrenia: a phosphorus 31 nuclear magnetic resonance spectroscopy study.

Authors:  Wolfgang Weber-Fahr; Susanne Englisch; Andrea Esser; Nuran Tunc-Skarka; Andreas Meyer-Lindenberg; Gabriele Ende; Mathias Zink
Journal:  Psychiatry Res       Date:  2013-09-14       Impact factor: 3.222

Review 10.  Clinical review: neuromonitoring - an update.

Authors:  Nino Stocchetti; Peter Le Roux; Paul Vespa; Mauro Oddo; Giuseppe Citerio; Peter J Andrews; Robert D Stevens; Tarek Sharshar; Fabio S Taccone; Jean-Louis Vincent
Journal:  Crit Care       Date:  2013-01-15       Impact factor: 9.097

View more
  3 in total

1.  Brain Tissue Damage Induced by Multimodal Neuromonitoring In Situ during MRI after Severe Traumatic Brain Injury: Incidence and Clinical Relevance.

Authors:  Daniel Pinggera; Paul Rhomberg; Ronny Beer; Claudius Thomé; Ondra Petr
Journal:  J Clin Med       Date:  2022-06-02       Impact factor: 4.964

2.  Cerebral Energy Status and Altered Metabolism in Early Brain Injury After Aneurysmal Subarachnoid Hemorrhage: A Prospective 31P-MRS Pilot Study.

Authors:  Stephanie Alice Treichl; Wing Mann Ho; Ruth Steiger; Astrid Ellen Grams; Andreas Rietzler; Markus Luger; Elke Ruth Gizewski; Claudius Thomé; Ondra Petr
Journal:  Front Neurol       Date:  2022-02-28       Impact factor: 4.003

Review 3.  Magnetic Resonance Spectroscopy in Diagnosis and Follow-Up of Gliomas: State-of-the-Art.

Authors:  Malik Galijasevic; Ruth Steiger; Stephanie Mangesius; Julian Mangesius; Johannes Kerschbaumer; Christian Franz Freyschlag; Nadja Gruber; Tanja Janjic; Elke Ruth Gizewski; Astrid Ellen Grams
Journal:  Cancers (Basel)       Date:  2022-06-29       Impact factor: 6.575

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.